Early adoption patterns of the recombinant zoster vaccine: real-world versus clinical trial populations.

BACKGROUND: Randomised controlled trials (RCTs) are essential for evaluating new vaccines but often exclude high-risk populations, creating uncertainties about vaccine performance across diverse populations. OBJECTIVES: We aimed to characterise recip…

Preview only. Read the full abstract at the source